Skip to main content
Equibles
DNLI $19.15 -3.82%
DNLI logo
DNLI · Denali Therapeutics Inc.
Track DNLI — free

Use DNLI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DNLI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$19.15 -0.76 (-3.82%)
Russell 2000 member Rebalance outlook locked
Market Cap
$3.25B
Shares
159.85M
Volume · Oct 6 197.12K Avg daily vol (3M) 1.57M
All webcasts

Earnings call · FY2020 Q3

Denali Therapeutics Inc. (DNLI) Q3 2020 Earnings Call

Concluded Nov 5, 2020
Nov 5, 2020 0 turns
Period
FY2020 Q3
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $9.39M -31% YoY
Diluted EPS -$0.54
Net income -$58.23M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 5, 2020 10-Q report Filed Nov 5, 2020
Full-screen source Call document

DNLI transcript alerts

Denali Therapeutics Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →